Answers are grounded in this paper and cite their sources.
Objective: Patients with schizophrenia have higher morbidity and mortality rates than the general population and a shorter life expectancy. While increased plasma triglyceride levels constitute a risk factor for cardiovascular diseases, metabolic disturbances are seen in patients with schizophrenia and in those on antipsychotics. This study assessed the triglyceride levels of patients with schizophrenia who were administered antipsychotic monotherapy in various treatment settings as a post-hoc analysis of a previous nationwide survey.
No takes yet. Share an insight, caveat, or question.
Ono et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: